11C-Sarcosine Detects Prostate Cancer Better Than Other Imaging Agents, Study Reports

11C-Sarcosine Detects Prostate Cancer Better Than Other Imaging Agents, Study Reports
A new PET imaging agent known as Carbon-11 labeled sarcosine, or 11C-sarcosine, detects prostate cancer better than the current agent, 11C-choline, University of Michigan researchers report. PET is short for positron-emission tomography. The imaging technique uses radioactive agents, or tracers, to try to identify diseases in a patient's body. This is usually done by looking at metabolic processes — that is, the way the body converts food to energy — which are often distinct in cancer and healthy cells. The Michigan team's study, published in The Journal of Nuclear Medicine, was titled “
Subscribe or to access all post and page content.